Delivery Order SPE2DB20D7061-SPE2DB25FSPU6
- Not listed
- The Defense Logistics Agency awarded a $4,057.92 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Omnipaque 350 mg/ml Pluspak 500ml, a diagnostic contrast agent used in medical imaging procedures. This firm fixed-price contract, with completion targeted for September 10, 2025, represents a competitively awarded, non-set-aside delivery order under AmerisourceBergen's larger pharmaceutical supply agreement. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Omnipaque 350 mg/mL Pluspak 500mL, a contrast medium used in medical imaging procedures. Valued at $5,410.56 with a firm fixed price structure, this non-set-aside delivery order represents a competitive award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate headquarters in...
- The Defense Logistics Agency awarded a $1,171.00 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Omnipaque 300 mg/mL contrast medium in 100 mL infusion bottles. This non-set-aside, firm fixed price delivery order is scheduled for completion by June 3, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a small-value transaction within the company's broader relationship with the Defense Logistics Agency's...
- The Defense Logistics Agency awarded a delivery order valued at $4,077.60 to AmerisourceBergen Drug Corp for the supply of Omnipaque 300 mg/mL infusion bottles (100 mL units). This firm fixed-price delivery order, issued on September 18, 2025, with completion targeted for September 19, 2025, represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Omnipaque is a contrast medium commonly used in...
- The Defense Logistics Agency awarded a $1,622.85 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for Omnipaque 300 mg/ml infusion bottles (100ml units). The contract, which is non-set-aside and competitively awarded, is scheduled for completion by August 5, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,582.41 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Omnipaque 180 mg/mL vials (10 mL units) on August 20, 2025, with a completion date of August 21, 2025. This non-set-aside competitive award will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00...
- The Defense Logistics Agency awarded a $3,043.44 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Omnipaque 350 mg/mL Pluspak 500ml, a contrast medium used in medical imaging procedures. This is a non-set-aside, competitively awarded contract with a completion date of June 17, 2025, and performance executed from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Omnipaque 300 mg/mL infusion bottles (100 mL units) under a firm fixed-price contract valued at $2,183.45. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 9, 2025. The product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,352.64 for Omnipaque 350 mg/ml Pluspak 500ml, a contrast agent used in diagnostic imaging procedures. The contract is a firm fixed price delivery order with an ultimate completion date of August 25, 2025, and represents a non-set-aside competitive award. Performance will be executed from the awardee's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,235.01 to AmerisourceBergen Drug Corp for Omnipaque 300 mg/ml vials (10 ml) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Omnipaque is a contrast medium used in medical imaging procedures, reflecting the company's role as a critical...
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB25FSPU6Delivery Order
The Defense Logistics Agency awarded a $4,997.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Omnipaque 300 mg/ml contrast medium in 100ml infusion bottles. The award, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a non-competitive set-aside delivery order for medical imaging supplies. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal healthcare systems, particularly military and veteran medical networks through the DLA Medical Supply Chain. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent contract serves as a comprehensive pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs globally, including products across multiple therapeutic domains and specialized medical commodities. The contract demonstrates AmerisourceBergen's capability to fulfill federal medical procurement requirements for critical diagnostic and therapeutic products supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 9/17/25 |